Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Membranous nephropathy: from models to man
Laurence H. Beck Jr., David J. Salant
Laurence H. Beck Jr., David J. Salant
Published June 2, 2014
Citation Information: J Clin Invest. 2014;124(6):2307-2314. https://doi.org/10.1172/JCI72270.
View: Text | PDF
Review Series Article has an altmetric score of 17

Membranous nephropathy: from models to man

  • Text
  • PDF
Abstract

As recently as 2002, most cases of primary membranous nephropathy (MN), a relatively common cause of nephrotic syndrome in adults, were considered idiopathic. We now recognize that MN is an organ-specific autoimmune disease in which circulating autoantibodies bind to an intrinsic antigen on glomerular podocytes and form deposits of immune complexes in situ in the glomerular capillary walls. Here we define the clinical and pathological features of MN and describe the experimental models that enabled the discovery of the major target antigen, the M-type phospholipase A2 receptor 1 (PLA2R). We review the pathophysiology of experimental MN and compare and contrast it with the human disease. We discuss the diagnostic value of serological testing for anti-PLA2R and tissue staining for the redistributed antigen, and their utility for differentiating between primary and secondary MN, and between recurrent MN after kidney transplant and de novo MN. We end with consideration of how knowledge of the antigen might direct future therapeutic strategies.

Authors

Laurence H. Beck Jr., David J. Salant

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Total
Citations: 3 5 5 10 12 8 5 9 6 11 8 1 83
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (83)

Title and authors Publication Year
Obinutuzumab in membranous nephropathy: a potential game-changer in treatment
Sessa C, Galeano D, Zanoli L, Delsante M, Rossi GM, Morale W
Drugs in Context 2025
Diagnostic Immunostaining of Renal Biopsies: An Overview of Markers for Glomerular Diseases
Agrawal V, Sharma A
Glomerular Diseases 2025
Trans-ethnic Mendelian randomization analysis of membranous nephropathy and peripheral artery disease with mediating effects of thrombomodulin
Pan J, Huang X, Chen Y, Jiang N, Guo Y, Zhou S, Zhang Y, Hu B, Deng Q, Zhou Q
Scientific Reports 2025
Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study.
Rui M, Jiang L, Pan JJ, Huang XT, Cui JF, Zhang SJ, He SM, Han HH, Chen X, Wang DD
International Urology and Nephrology 2024
Concurrent Crystalline Light-Chain Proximal Tubulopathy and Membranous Nephropathy: A Case Report and Literature Review.
Zhang H, Zhang C, Su H
2024
Identification and validation of biomarkers in membranous nephropathy and pan-cancer analysis
Yang Y, Zou GM, Wei XS, Zhang Z, Zhuo L, Xu QQ, Li WG
Frontiers in immunology 2024
C3d-Targeted factor H inhibits tissue complement in disease models and reduces glomerular injury without affecting circulating complement
Liu F, Ryan ST, Fahnoe KC, Morgan JG, Cheung AE, Storek MJ, Best A, Chen HA, Locatelli M, Xu S, Schmidt E, Schmidt-Jiménez LF, Bieber K, Henderson JM, Lian CG, Verschoor A, Ludwig RJ, Benigni A, Remuzzi G, Salant DJ, Kalled SL, Thurman JM, Holers VM, Violette SM, Wawersik S
Molecular Therapy 2024
Clinical glycoproteomics: methods and diseases.
Wang Y, Lei K, Zhao L, Zhang Y
MedComm 2024
Clinical covariates influencing clinical outcomes in primary membranous nephropathy
Westermann L, Rottmann FA, Hug MJ, Staudacher DL, Wobser R, Arnold F, Welte T
BMC Nephrology 2023
Membranous Nephropathy in Syphilis is Associated with Neuron-Derived Neurotrophic Factor.
Sethi S, Madden B, Casal Moura M, Singh RD, Nasr SH, Hou J, Sharma A, Nath KA, Specks U, Fervenza FC, Haas M
Journal of the American Society of Nephrology : JASN 2023
Knowledge Translation in Glomerulonephritis: Successes in Translational Research From the Bench to Bedside
Yau K, Wang C, Al Batran R, Macphee A, Beaucage M, Farragher JF
Canadian Journal of Kidney Health and Disease 2023
Identification of biomarkers related to immune and inflammation in membranous nephropathy: comprehensive bioinformatic analysis and validation
Zhang P, Geng Y, Tang J, Cao Z, Xiang X, Yang K, Chen H
Frontiers in immunology 2023
Large B-cell Lymphoma-Associated Membranous Nephropathy With Positive PLA2R on Kidney Biopsy.
Al-Khazraji M, Al-Mufti IA, Al-Khazraji Y
Cureus 2023
Negative modulation of B cell activation by MC1R signaling protects against membranous nephropathy
Bohan Chen, Xuejing Guan, William Gunning, Yan Ge, Amira Gohara, Lance Dworkin, Rujun Gong
Journal of the American Society of Nephrology : JASN 2022
The Role of Anti-PLA2R and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice
I Smarz-Widelska, D Chojęta, M Kozioł
International journal of environmental research and public health 2022
Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1
Sethi S, Madden B, Casal Moura M, Nasr SH, Klomjit N, Gross L, Negron V, Charlesworth MC, Alexander MP, Leung N, Specks U, Fervenza FC, Haas M
Journal of the American Society of Nephrology : JASN 2022
The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy
Manral P, Caza TN, Storey AJ, Beck LH Jr, Borza DB
Frontiers in immunology 2022
Molecular Characterization of Membranous Nephropathy.
Sealfon R, Mariani L, Avila-Casado C, Nair V, Menon R, Funk J, Wong A, Lerner G, Hayashi N, Troyanskaya O, Kretzler M, Beck LH Jr
Journal of the American Society of Nephrology : JASN 2022
Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy
Miao H, Zhang Y, Yu X, Zou L, Zhao Y
Frontiers in pharmacology 2022
Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Molecular Mechanism of Triptolide in the Treatment of Membranous Nephropathy
Zhang PN, Tang JY, Yang KZ, Zheng QY, Dong ZC, Geng YL, Liu YN, Liu WJ
Drug design, development and therapy 2022
Toxic Occupational Exposures and Membranous Nephropathy
Cremoni M, Agbekodo S, Teisseyre M, Zorzi K, Brglez V, Benzaken S, Esnault V, Planchard JH, Seitz-Polski B
Clinical journal of the American Society of Nephrology : CJASN 2022
The Many Faces of NELL1 MN
Sethi S
Clinical Kidney Journal 2022
Investigation of Urinary Exosome Metabolic Patterns in Membranous Nephropathy by Titania‐Assisted Intact Exosome Mass Spectrometry
Chen H, Zhang N, Wu Y, Yang C, Xie Q, Deng C, Sun N
Small Science 2022
Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1 associated membranous nephropathy
George Haddad, Johan M. Lorenzen, Hong Ma, Noortje de Haan, Harald Seeger, Christelle Zaghrini, Simone Brandt, Malte Kölling, Urs Wegmann, Bence Kiss, Gábor Pál, Péter Gál, Rudolf P. Wuthrich, Manfred Wuhrer, Laurence H. Beck, David J. Salant, Gérard Lambeau, Andreas D. Kistler
Journal of Clinical Investigation 2021
Immunohistochemical Expression of FOXP3+ Regulatory T Cells in Proteinuric Primary Glomerulopathies
G Vlachopanos, A Georgalis, P Korkolopoulou, E Patsouris, H Gakiopoulou, F Anglani
International Journal of Nephrology 2021
Mechanisms of Primary Membranous Nephropathy
Y Gu, H Xu, D Tang
Biomolecules 2021
Patients with Proliferative Lupus Nephritis Have Autoantibodies That React to Moesin and Demonstrate Increased Glomerular Moesin Expression
DJ Caster, EA Korte, ML Merchant, JB Klein, MT Barati, A Joglekar, DW Wilkey, S Coventry, J Hata, BH Rovin, JB Harley, B Namjou-Khales, KR McLeish, DW Powell
Journal of Clinical Medicine 2021
Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy
E Jatem-Escalante, ML Martín-Conde, E Gràcia-Lavedan, ID Benítez, J Gonzalez, L Colás, A Garcia-Carrasco, C Martínez, A Segarra-Medrano
Clinical Kidney Journal 2021
Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials
H Huang, Z Liang, X Zheng, Q Qing, X Du, Z Tang, M Wei, C Wang, Q Zhong, X Lin
Renal Failure 2021
The Diagnostic and Prognostic Potential of the B-Cell Repertoire in Membranous Nephropathy
Z Su, Y Jin, Y Zhang, Z Guan, H Li, X Chen, C Xie, C Zhang, X Liu, P Li, P Ye, L Zhang, Y Kong, W Luo
Frontiers in immunology 2021
A cohort study of membranous nephropathy, primary or secondary
M Arghiani, BH Zamani, F Nazemian, S Samadi, MS Afsharian, M Habibzadeh, S Eslami, MG Sabbagh
BMC Nephrology 2021
Complete Resolution of Paraneoplastic Membranous Nephropathy Following Curative Therapy of Triple-Negative Breast Cancer
MB Khan, A Kaur, A Ali, A Boris, S Spitalewitz
Cureus 2021
A PLA2R-IgG4 Antibody-Based Predictive Model for Assessing Risk Stratification of Idiopathic Membranous Nephropathy
X Liu, J Xue, X Guo, Y Ding, Y Zhang, X Zhang, Y Huang, B Huang, Z Hu, G Lu, L Wang, S Gong
Journal of Healthcare Engineering 2021
Protocadherin 7–Associated Membranous Nephropathy
S Sethi, B Madden, H Debiec, J Morelle, MC Charlesworth, LA Gross, V Negron, D Buob, S Chaudhry, M Jadoul, FC Fervenza, P Ronco
Journal of the American Society of Nephrology : JASN 2021
Sanqi Oral Solution Mitigates Proteinuria in Rat Passive Heymann Nephritis and Blocks Podocyte Apoptosis via Nrf2/HO-1 Pathway
X Wang, J Liu, R Tian, B Zheng, C Li, L Huang, Z Lu, J Zhang, W Mao, B Liu, K Bao, P Xu
Frontiers in pharmacology 2021
Loss of Roundabout Guidance Receptor 2 (Robo2) in Podocytes Protects Adult Mice from Glomerular Injury by Maintaining Podocyte Foot Process Structure
A Pisarek-Horowitz, X Fan, S Kumar, HM Rasouly, R Sharma, H Chen, K Coser, CT Bluette, D Hirenallur-Shanthappa, SR Anderson, H Yang, LH Beck, RG Bonegio, JM Henderson, SP Berasi, DJ Salant, W Lu
The American Journal of Pathology 2020
Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study
P Yin, J Wang, W Liang, L Zhan, Y Liu, J Lin, X Chen, Y He, H Jian, Z Xie, X Tan, Q Ye, F Huang
Renal Failure 2020
Single-nucleotide polymorphism rs4664308 in PLA2R1 gene is associated with the risk of idiopathic membranous nephropathy: a meta-analysis
M Yoshikawa, K Asaba
Scientific Reports 2020
Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses
M Cremoni, V Brglez, S Perez, F Decoupigny, K Zorzi, M Andreani, A Gérard, S Boyer-Suavet, C Ruetsch, S Benzaken, V Esnault, B Seitz-Polski
Frontiers in immunology 2020
Differential Expression of Urinary Exosomal Small RNAs in Idiopathic Membranous Nephropathy
J Zhang, Y Zhu, R Cai, J Jin, Q He, P Esposito
BioMed Research International 2020
The Landscape and Prognosis Potential of the T-Cell Repertoire in Membranous Nephropathy
Y Zhang, Y Jin, Z Guan, H Li, Z Su, C Xie, X Chen, X Liu, Y Pan, P Ye, L Zhang, Y Kong, W Luo
Frontiers in immunology 2020
Clinicopathological features and prognosis in patients with idiopathic membranous nephropathy with hypertension
W Lu, S Gong, J Li, Y Wang
Experimental and therapeutic medicine 2020
Clinical efficacy and safety of rituximab with membranous nephropathy: a meta-analysis.
Zhong H, Li HY, Zhou T, Zhong Z
Archives of Medical Science : AMS 2020
Complement Therapeutics in Autoimmune Disease
JM Thurman, R Yapa
Frontiers in immunology 2019
A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier
A Petrosyan, P Cravedi, V Villani, A Angeletti, J Manrique, A Renieri, RE Filippo, L Perin, SD Sacco
Nature Communications 2019
Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy: a meta-analysis
D Dong, T Fan, Y Wang, L Zhang, L Song, L Zhang
BMC Nephrology 2019
Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy
PD Burbelo, M Joshi, A Chaturvedi, DJ Little, JS Thurlow, M Waldman, SW Olson
Journal of the American Society of Nephrology : JASN 2019
Membranous Glomerulonephritis With Crescents
A Nikolopoulou, I Huang-Doran, SP McAdoo, ME Griffith, HT Cook, CD Pusey
Kidney International Reports 2019
A New Classification System for IgG4 Autoantibodies
I Koneczny
Frontiers in immunology 2018
Human anti-thrombospondin type 1 domain-containing 7A antibodies induce membranous nephropathy through activation of lectin complement pathway
Z Wang, L Wen, Y Dou, Z Zhao
Bioscience Reports 2018
Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy
W Luo, F Olaru, JH Miner, LH Beck, J van der Vlag, JM Thurman, DB Borza
Frontiers in immunology 2018
Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy
M Tampoia, F Migliucci, C Villani, L Abbracciavento, M Rossini, R Fumarulo, L Gesualdo, V Montinaro
Journal of Nephrology 2018
Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China
D Zhang, J Zou, C Zhang, W Zhang, F Lin, G Jiang
Medical science monitor : international medical journal of experimental and clinical research 2018
Expression of immunoglobulin G in human podocytes, and its role in cell viability and adhesion
Z Jing, H Deng, J Ma, Y Guo, Y Liang, R Wu, L A, Z Geng, X Qiu, Y Wang
International journal of molecular medicine 2018
Management of Membranous Nephropathy in the PLA 2 R Era
AS Bomback
Clinical journal of the American Society of Nephrology : CJASN 2018
Clinical value of a serum anti-PLA2R antibody in the diagnosis and monitoring of primary membranous nephropathy in adults
X Wu, L Liu, Y Guo, L Yang
International journal of nephrology and renovascular disease 2018
Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy
F von Haxthausen, L Reinhard, HO Pinnschmidt, M Rink, A Soave, E Hoxha, RA Stahl
Frontiers in immunology 2018
Prospects for Precision Medicine in Glomerulonephritis Treatment
YC Liu, J Chun
Canadian Journal of Kidney Health and Disease 2017
Blockage of the lysosome-dependent autophagic pathway contributes to complement membrane attack complex-induced podocyte injury in idiopathic membranous nephropathy
WJ Liu, Z Li, X Chen, X Zhao, Z Zhong, C Yang, H Wu, N An, W Li, H Liu
Scientific Reports 2017
Membranous Glomerulopathy With Light Chain–Restricted Deposits: A Clinicopathological Analysis of 28 Cases
AB Rocha, CP Larsen
Kidney International Reports 2017
Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents
AK Dettmar, T Wiech, MJ Kemper, A Soave, M Rink, J Oh, RA Stahl, E Hoxha
Pediatric Nephrology 2017
Variants in the Promoter Region of HLA-DQA1 were Associated with Idiopathic Membranous Nephropathy in a Chinese Han Population
XS Qin, JH Liu, GT Lu, ML Peng, FN Yang, DC Qin, YZ Li, Y Liu
Chinese Medical Journal 2017
Membranous nephropathy—one morphologic pattern with different diseases
E Hoxha, F von Haxthausen, T Wiech, RA Stahl
Pflügers Archiv - European Journal of Physiology 2017
Autoantibodies against thrombospondin type-1 domain-containing 7A induce membranous nephropathy
Nicola Tomas, Elion Hoxha, Anna T. Reinicke, Lars Fester, Udo Helmchen, Jens Gerth, Friederike Bachmann, Klemens Budde, Friedrich Koch-Nolte, Gunther Zahner, Gabriele Rune, Gérard Lambeau, Catherine Meyer-Schwesinger, Rolf A.K. Stahl
Journal of Clinical Investigation 2016
Biologics for the treatment of autoimmune renal diseases
SR Holdsworth, PY Gan, AR Kitching
Nature Reviews Nephrology 2016
Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy
DB Borza
Frontiers in immunology 2016
Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy
T Fujino, N Hasebe
BMC Nephrology 2016
Transcriptomic Segregation of Human Autoantigens Useful for the Diagnosis of Autoimmune Diseases
PD Burbelo, MJ Iadarola, I Alevizos, MR Sapio
Molecular diagnosis & therapy 2016
Clinicopathological features of idiopathic membranous nephropathy combined with IgA nephropathy: a retrospective analysis of 9 cases
R Hu, G Xing, H Wu, Z Zhang
Diagnostic Pathology 2016
Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy
H Dong, Y Wang, X Cheng, G Wang, L Sun, H Cheng, Y Chen, V Jha
PloS one 2016
A Proposal for a Serology-Based Approach to Membranous Nephropathy
AS de Vriese, RJ Glassock, KA Nath, S Sethi, FC Fervenza
Journal of the American Society of Nephrology : JASN 2016
Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies
P Sekula, Y Li, HC Stanescu, M Wuttke, AB Ekici, D Bockenhauer, G Walz, SH Powis, JT Kielstein, P Brenchley, KU Eckardt, F Kronenberg, R Kleta, A Köttgen
Nephrology Dialysis Transplantation 2016
Anti-Phospholipase A2 Receptor Autoantibody: A New Biomarker for Primary Membranous Nephropathy
Q Zhu
Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry 2016
Biomarkers to detect membranous nephropathy in Chinese patients
L Lin, WM Wang, XX Pan, J Xu, CN Gao, W Zhang, H Ren, JY Xie, PY Shen, YW Xu, LY Ni, N Chen
Oncotarget 2016
Crescentic glomerulonephritis and membranous nephropathy: a rare coexistence
O Balafa, R Kalaitzidis, G Liapis, S Xiromeriti, F Zarzoulas, G Baltatzis, M Elisaf
International Urology and Nephrology 2015
Non-immunologic targets of immunosuppressive agents in podocytes
TH Yoo, A Fornoni
Kidney Research and Clinical Practice 2015
Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related Disease
S Buelli, L Perico, M Galbusera, M Abbate, M Morigi, R Novelli, E Gagliardini, C Tentori, D Rottoli, E Sabadini, T Saito, M Kawano, T Saeki, C Zoja, G Remuzzi, A Benigni
EBioMedicine 2015
Comparison of biomarkers between PLA2RAb+ and PLA2RAb− in patients with idiopathic membranous nephropathy
C Xun, L shuai, W Wang, Y Jiang
International Urology and Nephrology 2015
Changing the concepts of immune-mediated glomerular diseases through proteomics
DJ Caster, L Hobeika, JB Klein, DW Powell, KR McLeish
PROTEOMICS – CLINICAL APPLICATIONS 2015
Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease: A Retrospective Study of 10 Cases
M Dauvergne, A Moktefi, M Rabant, C Vigneau, T Kofman, S Burtey, C Corpechot, T Stehlé, D Desvaux, N Rioux-Leclercq, P Rouvier, B Knebelmann, JJ Boffa, T Frouget, E Daugas, M Jablonski, K Dahan, I Brocheriou, P Remy, P Grimbert, P Lang, O Chazouilleres, D Sahali, V Audard
Medicine 2015
Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy
B Obrisca, G Ismail, R Jurubita, C Baston, A Andronesi, G Mircescu
BioMed Research International 2015
Human Urine Proteomics: Analytical Techniques and Clinical Applications in Renal Diseases
S Kalantari, A Jafari, R Moradpoor, E Ghasemi, E Khalkhal
International Journal of Proteomics 2015
Kidney disease: new technologies translate mechanisms to cure
John O'Toole, John Sedor
Journal of Clinical Investigation 2014

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 6 X users
Referenced in 3 patents
Referenced in 1 Wikipedia pages
124 readers on Mendeley
1 readers on CiteULike
See more details